1. Clinical outcomes of peripheral blood stem cell transplantation for aggressive peripheral T-cell lymphoma
Wenrong HUANG ; Zhenyang GU ; Honghua LI ; Jian BO ; Shuhong WANG ; Fei LI ; Xiaoning GAO ; Liping DOU ; Yu ZHAO ; Yu JING ; Haiyan ZHU ; Qunshun WANG ; Li YU ; Chunji GAO ; Daihong LIU
Chinese Journal of Hematology 2018;39(9):729-733
Objective:
To evaluate clinical outcomes of autologous and allogeneic peripheral blood stem cell transplantation (PBSCT) for aggressive peripheral T-cell lymphoma (PTCL).
Methods:
From June 2007 to June 2017, clinical data of PTCL patients who underwent PBSCT were assessed retrospectively.
Results:
Among 41 patients, 30 was male, 11 female, and median age was 38(13-57) years old. Seventeen patients with autologous PBSCT (auto-PBSCT) and 24 patients with allogeneic PBSCT (allo-PBSCT) were enrolled in this study. Eight patients (8/17, 47.1%) in auto-PBSCT group were ALK positive anaplastic large cell lymphoma (ALCL), 7 patients (7/24, 29.2%) with NK/T cell lymphoma and 9 patients (9/24, 37.5%) with PTCL-unspecified (PTCL-U) in allo-PBSCT group (